Logo image
Back
Mortality, Cost, and Downstream Disease of Total Hip Medicare Population
Journal article   Peer reviewed

Mortality, Cost, and Downstream Disease of Total Hip Medicare Population

Scott T. Lovald, Kevin L. Ong, Edmund C. Lau, Jordana K. Schmier, Kevin J. Bozic and Steve M. Kurtz
The Journal of arthroplasty, v 29(1), pp 242-246
01 Jan 2014
DOI: https://doi.org/10.1016/j.arth.2013.04.031
PMID: 23711799
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Life Sciences & Biomedicine Orthopedics Science & Technology
The purpose of this study is to compare the differences in downstream cost and health outcomes between Medicare hip OA patients who undergo total hip arthroplasty (THA) and those who do not. All OA patients in the Medicare 5% sample (1998-2009) were separated into non-THA and THA groups. Differences in costs and risk ratios for mortality and new disease diagnoses were adjusted using logistic regression for age, sex, race, socioeconomic status, region, and Charlson score. Mortality, heart failure, depression, and diabetes were all reduced in the THA group, though there was an increased risk for atherosclerosis in the short term. The potential for selection bias was investigated with two separate propensity score analyses. This study demonstrates the potential benefit of THA in reducing mortality and improving aspects of overall health in OA patients. (C) 2014 Elsevier Inc. All rights reserved.

Metrics

11 Record Views
22 citations in Web of Science
21 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Orthopedics
Logo image